Heparin-induced thrombocytopenia

被引：339

作者：

Arepally, Gowthami M.

Ortel, Thomas L.

机构：

[1] Duke Univ, Med Ctr, Dept Med, Div Hematol, Durham, NC 27710 USA

[2] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2006年 / 355卷 / 08期

关键词：

D O I：

10.1056/NEJMcp052967

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A 63-year-old man with coronary artery disease who has recently undergone bypass surgery presents with dyspnea. Findings on physical examination are unremarkable. Laboratory testing reveals a platelet count of 86,000 per cubic millimeter, as compared with 225,000 per cubic millimeter at the time of discharge nine days earlier. The results of chest radiography are unremarkable; spiral computed tomography of the chest shows a pulmonary embolism. Heparin-induced thrombocytopenia is suspected. What diagnostic studies are warranted, and how should this patient be treated? Copyright © 2006 Massachusetts Medical Society.

引用

收藏

页码：809 / 817

页数：9

相关论文

共 51 条

[1]

AMIRAL J, 1992, THROMB HAEMOSTASIS, V68, P95

[2] Presence of autoantibodies to interleukin-8 or neutrophil-activating peptide-2 in patients with heparin-associated thrombocytopenia [J].

Amiral, J ;

MarfaingKoka, A ;

Wolf, M ;

Alessi, MC ;

Tardy, B ;

BoyerNeumann, C ;

Vissac, AM ;

Fressinaud, E ;

Poncz, M ;

Meyer, D .

BLOOD, 1996, 88 (02) :410-416

[3]

[Anonymous], CHEST

[4] Prospective randomised open-label comparison of danaparoid with dextran 70 in the treatment of heparin-induced thrombocytopaenia with thrombosis - A clinical outcome study [J].

Chong, BH ;

Gallus, AS ;

Cade, JF ;

Magnani, H ;

Manoharan, A ;

Oldmeadow, M ;

Arthur, C ;

Rickard, K ;

Gallo, J ;

Lloyd, J ;

Seshadri, P ;

Chesterman, CN .

THROMBOSIS AND HAEMOSTASIS, 2001, 86 (05) :1170-1175

[5] Risk factors for thrombosis in patients with immune mediated heparin-induced thrombocytopenia [J].

Fabris, F ;

Luzzatto, G ;

Soini, B ;

Ramon, R ;

Scandellari, R ;

Randi, ML ;

Girolami, A .

JOURNAL OF INTERNAL MEDICINE, 2002, 252 (02) :149-154

[6] A comparison of danaparoid and lepirudin in heparin-induced thrombocytopenia [J].

Farner, B ;

Eichler, P ;

Kroll, H ;

Greinacher, A .

THROMBOSIS AND HAEMOSTASIS, 2001, 85 (06) :950-957

[7] Heparin-induced thrombocytopenia is rare in pregnancy [J].

Fausett, MB ;

Vogtlander, M ;

Lee, RM ;

Esplin, MS ;

Branch, DW ;

Rodgers, GM ;

Silver, RM .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2001, 185 (01) :148-152

[8] The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study [J].

Girolami, B ;

Prandoni, P ;

Stefani, PM ;

Tanduo, C ;

Sabbion, P ;

Eichler, P ;

Ramon, R ;

Baggio, G ;

Fabris, F ;

Girolami, A .

BLOOD, 2003, 101 (08) :2955-2959

[9] Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy [J].

Greer, IA ;

Nelson-Piercy, C .

BLOOD, 2005, 106 (02) :401-407

[10] Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis [J].

Greinacher, A ;

Farner, B ;

Kroll, H ;

Kohlmann, T ;

Warkentin, TE ;

Eichler, P .

THROMBOSIS AND HAEMOSTASIS, 2005, 94 (01) :132-135

← 1 2 3 4 5 6 →